loadpatents
name:-0.029927015304565
name:-0.015302181243896
name:-0.0023131370544434
GWAG; Byoung Joo Patent Filings

GWAG; Byoung Joo

Patent Applications and Registrations

Patent applications and USPTO patent grants for GWAG; Byoung Joo.The latest application filed is for "cosmetic composition including 5-benzylaminosalicylic acid derivative, and topical use thereof".

Company Profile
2.16.26
  • GWAG; Byoung Joo - Yongin-si KR
  • Gwag; Byoung Joo - Suwon-si N/A KR
  • GWAG; Byoung Joo - Gyeonggi-do KR
  • Gwag; Byoung Joo - Seoul KR
  • Gwag; Byoung-Joo - Suwon Gyeonggi-Do KR
  • GWAG; Byoung Joo - Suwon-shi KR
  • Gwag; Byoung-Joo - Kyunggi-do KR
  • Gwag, Byoung Joo - Seocho-ku KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cosmetic Composition Including 5-benzylaminosalicylic Acid Derivative, And Topical Use Thereof
App 20220249343 - SHIN; Jin Hee ;   et al.
2022-08-11
Compositions And Methods For Treating Neurodegenerative Disorders
App 20220241231 - LEE; Jinhwan ;   et al.
2022-08-04
Compositions And Methods For Treating Reperfusion Injury Or Hemorrhage After Recanalization Therapy
App 20210283080 - Gwag; Byoung Joo ;   et al.
2021-09-16
Compositions And Methods For Treating Neurodegenerative Disorders
App 20200206172 - Lee; Jinhwan ;   et al.
2020-07-02
Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
Grant 8,686,185 - Gwag , et al. April 1, 2
2014-04-01
Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
Grant 8,598,383 - Gwag , et al. December 3, 2
2013-12-03
Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases
App 20130316988 - GWAG; Byoung Joo ;   et al.
2013-11-28
Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
Grant 8,455,470 - Gwag , et al. June 4, 2
2013-06-04
Compounds And Compositions For Treating Neuronal Death Or Neurological Dysfunction
App 20120301551 - GWAG; Byoung Joo ;   et al.
2012-11-29
Pharmaceutical Composition For Treating Or Preventing Burn Injuries
App 20120289602 - Gwag; Byoung-Joo ;   et al.
2012-11-15
Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases
App 20120209025 - GWAG; Byoung-Joo ;   et al.
2012-08-16
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
Grant 8,211,877 - Gwag , et al. July 3, 2
2012-07-03
Method for reducing neuronal death in nervous system injuries resulting from amyotrophic lateral sclerosis
Grant 8,211,878 - Gwag , et al. July 3, 2
2012-07-03
Medicinal Use Of 5-benzylaminosalicylic Acid Derivative Or Its Salt
App 20120040939 - Gwag; Byoung-Joo ;   et al.
2012-02-16
Manufacturing Method Of 2-hydroxy-5-phenylalkylaminobenzoic Acid Derivatives And Their Salts
App 20110028757 - Gwag; Byoung Joo ;   et al.
2011-02-03
Compounds, Compositions And Methods For Preventing Neurodegeneration In Acute And Chronic Injuries In The Central Nervous System
App 20100331284 - GWAG; Byoung Joo ;   et al.
2010-12-30
Compounds, Compositions And Methods For Preventing Neurodegeneration In Acute And Chronic Injuries In The Central Nervous System
App 20100323995 - GWAG; Byoung Joo ;   et al.
2010-12-23
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
Grant 7,750,045 - Gwag , et al. July 6, 2
2010-07-06
Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases
App 20090281181 - Gwag; Byoung-Joo ;   et al.
2009-11-12
Compositions for inhibition of necrosis induced by a neurotrophin
Grant 7,608,585 - Gwag , et al. October 27, 2
2009-10-27
Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases
App 20090240079 - GWAG; Byoung-Joo ;   et al.
2009-09-24
Compounds And Compositions For Treating Neuronal Death Or Neurological Dysfunction
App 20090149542 - GWAG; Byoung Joo ;   et al.
2009-06-11
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Grant 7,511,074 - Gwag , et al. March 31, 2
2009-03-31
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
App 20080227859 - Gwag; Byoung-Joo ;   et al.
2008-09-18
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Grant 7,371,896 - Gwag , et al. May 13, 2
2008-05-13
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Grant 7,319,160 - Gwag , et al. January 15, 2
2008-01-15
Compounds and compositions for treating neuronal death or neurological dysfunction
App 20070298129 - Gwag; Byoung Joo ;   et al.
2007-12-27
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
App 20070078183 - Gwag; Byoung-Joo ;   et al.
2007-04-05
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Grant 7,189,878 - Gwag , et al. March 13, 2
2007-03-13
Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction
App 20070049565 - Gwag; Byoung Joo ;   et al.
2007-03-01
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
App 20060235239 - Gwag; Byoung-Joo ;   et al.
2006-10-19
Method for inhibition of necrosis induced by neurotrophin
App 20060135600 - Gwag; Byoung-Joo ;   et al.
2006-06-22
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
App 20060128677 - Gwag; Byoung Joo ;   et al.
2006-06-15
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
Grant 6,964,982 - Gwag , et al. November 15, 2
2005-11-15
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
App 20050239896 - Gwag, Byoung-Joo ;   et al.
2005-10-27
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Grant 6,927,303 - Gwag , et al. August 9, 2
2005-08-09
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
App 20040209957 - Gwag, Byoung-Joo ;   et al.
2004-10-21
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
App 20030097018 - Gwag, Byoung Joo ;   et al.
2003-05-22
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
App 20030045575 - Gwag, Byoung Joo ;   et al.
2003-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed